Patient Recruitment & Retention for Clinical Trials | Allucent
Home  /  Solutions  /  Clinical Development  /  Patient Recruitment & Retention
Patient Recruitment & Retention

Tailored Patient-centric Solutions to Maximize Clinical Trial Recruitment & Retention

SCROLL Patient Recruitment

The Patient Pathway to Better Clinical Trial Recruitment & Retention

Allucent’s Patient Engagement Group utilizes a patient pathway methodology to ensure smarter patient recruitment, stronger engagement, and more inclusive participation across all trial designs from traditional on-site to fully decentralized models.

Through a combination of in-house expertise, strategic site partnerships, tech-enabled solutions, and IGNITE™, our global site network of pre‑qualified therapeutically aligned research sites, we deliver agile, scalable strategies that accelerate patient recruitment from first-patient-in (FPI) through to the last patient enrolled and improve retention by supporting successful trial execution from start to finish.

Comprehensive Patient Recruitment & Retention Services

  • Global reach with high-performing site access across key geographies
  • IGNITE™ site network accelerates site activation and study start-up
  • Data-driven site and patient identification for predictable enrollment
  • Patient-focused communications that strengthen recruitment and retention
  • PAG and community engagement to enhance participation and support
  • Travel and concierge support to remove barriers to trial participation
Site Networks & Support

Clinical Trial Site Support

Sites are the cornerstone of successful patient recruitment and retention, and our sites enhance efficiency, reach, and quality.

Diversity & Inclusion - Patient Recruitment

Special Patient Populations

Ensuring diversity and access to special patient populations for clinical trial participation is essential as people of different ages, races, ethnicities, genders, socioeconomic backgrounds, geographic locations, and disease characteristics may experience treatments differently.

patient-recruitment

Patient Advocacy Group (PAG) Engagement & Recruitment Support

Patient advocacy groups can be instrumental in bridging the gap between clinical researchers and participants.

Patient Education & Information

Patient Engagement & Education

Educated patients are more likely to stay engaged and less likely to drop out if they have realistic expectations of processes and outcomes.

Digital Patient Recruitment

Digital Patient Recruitment & Outreach

Digital technology plays a pivotal role in modernizing and increasing access to clinical trials for participants.

Decentralized Clinical Trial Solutions

Allucent has extensive experience across multiple aspects of decentralized trials including both fully virtual and hybrid approaches. Hybrid and Decentralized Clinical Trials (DCTs) offer great potential to rethink and refresh the traditional clinical trial models, enabling patients to interact with clinical researchers away from the traditional site setting.

To maximize the benefits of DCT solutions, DCT elements should be incorporated during the protocol design process to ensure seamless implementation and operational success. When successfully executed, DCTs can reduce the patient burden of participation, improve accessibility, and increase access to a wider geographically dispersed and diverse patient population.

Advantages of Decentralized Clinical Trials

  • Expand Patient Access
  • Accelerate Patient Recruitment
  • Improve Patient Engagement & Retention
  • Capture Higher-Quality Clinical Data
  • Enhance Patient Safety & Experience
  • Increase Operational Efficiency
  • Enhance Trial Continuity
  • Reduce Costs & Environmental Impact

Allucent Decentralized Ecosystem

Digital Patient Assessments Digital Patient Assessments
Virtual Patient Care Virtual Patient Care
Connected Data Capture & Analytics Connected Data Capture & Analytics
Digital Consent & Patient Education Digital Consent & Patient Education
Patient Engagement & Compliance Patient Engagement & Compliance
Direct-to-Patient Trial Logistics Direct-to-Patient Trial Logistics

Electronic Clinical Outcome Assessments (eCOA) simplify the collection of patient, clinician, and caregiver data while improving participant convenience, compliance, and data quality. Allucent delivers integrated, secure eCOA solutions that provide reliable, real-time data to support efficient decentralized clinical trial execution.

Telehealth and home health services enable clinical trials to reach participants wherever they are, reducing the burden of participation while maintaining the human connection between patients and care teams. Through trusted strategic partners, we deliver virtual visits and in-home clinical services that make participation easier for patients and their families, improve access to care, and support long-term engagement throughout the study.

Thanks to state-of-the-art technology, data capture is streamlined across sites, remote settings, telehealth visits, and connected devices. Real-time clinical trial performance data, together with predictive insights into enrollment, retention, and study completion, are delivered through an integrated dashboard to support faster, more informed decision-making.

Wearables and medical devices further extend this connected ecosystem by enabling participants to capture data seamlessly from home. Easy-to-use technologies improve the participant experience while supporting robust, high-quality data collection for exploratory, secondary, and even primary endpoints.

Compliant eConsent and integrated patient education provide a secure, convenient, and engaging participant experience. Participants can electronically review and sign consent forms, access study materials and instructional videos, and receive guidance for at-home activities such as IMP administration and sample collection. Integrated eDiary tracking supports protocol compliance while meeting local regulatory requirements.

Manage patient interactions throughout the trial through direct notifications and reminders ensuring participants are well-informed, engaged, and compliant with the trial requirements, which in turn supports the trial’s success. By raising site notifications based upon correct triggers, sites are directed to support those participants that require guidance and ensure all data is collected as required for the trial.

We partner with trusted providers to deliver IMP, test kits, and other clinical supplies directly to participants homes. Direct-to-patient logistics reduce the need for site visits, improve participant convenience, support protocol adherence, and help keep studies on track through coordinated communication with both participants and sites.

Successful trials start with engaged patients. Through our recruitment solutions and trusted site networks, we accelerate enrollment and shorten timelines to help bring your therapies to the patients who need them sooner.

Almenia Garvey

Senior Director, Global Study Start-Up, Site & Patient Engagement

Other Areas of Expertise

Additional Resources

Frequently Asked Questions About Clinical Trial Recruitment

Patient recruitment involves identifying and enrolling eligible participants into a clinical trial, while patient retention focuses on maintaining patient engagement throughout the study. Both are essential to generating the high-quality clinical evidence needed to demonstrate a therapy's safety and efficacy, support regulatory approval, and help sponsors achieve critical development milestones.
Patient retention is essential to generating complete and reliable data needed to evaluate a therapy’s safety and efficacy. High retention rates reduce missing data, strengthen study validity, avoid study delays, and improve the quality of trial results.
Common challenges include identifying eligible patients, raising awareness of clinical trials, increasing competition for participants, reaching diverse populations, meeting complex eligibility criteria, and keeping participants engaged throughout the study. Travel requirements, time commitments, and limited access to trial sites can also affect recruitment and retention, especially in rare disease and global clinical trials.
Allucent helps sponsors accelerate patient recruitment and improves retention through targeted engagement strategies, established site network relationships, digital patient recruitment, and patient advocacy group partnerships. The team also provides travel and concierge services, patient education, and support for on-site, decentralized, and hybrid clinical trials in 60+ countries.
Allucent supports patient recruitment and retention for all phases of clinical development, from phase I first-in-human to post-marketing studies. Our strategies are designed to help sponsors meet challenging of enrollment goals for complex clinical trials, maintain participant engagement, and generate the high-quality data needed to support development and regulatory decisions.

Partner With the A-Team

Let us know how we can help you bring new therapies to light. Get in touch to get started.

Join the A-Team

Want to help small and mid-size biopharma companies change the therapeutic landscape?

Subscribe to our monthly newsletter